Reema Railkar
-
- Photodynamic Therapy Research Studies 6
-
- Cancer, Hypoxia, and Metabolism 7
- Cancer, Lipids, and Metabolism 3
-
- Nanoplatforms for cancer theranostics 3
-
- Cancer-related Molecular Pathways 3
-
- Bladder and Urothelial Cancer Treatments 7
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Epigenetics and DNA Methylation 2
- Co-authors
- Piyush K. AgarwalThomas SanfordHisataka KobayashiPeter L. ChoykeDiana C. HainesRajan R. DigheRitankar MajumdarSrinivas Vourganti
- Journals
- Journal of Clinical Oncology (3 papers)Scientific Reports (2 papers)Cancer Research (2 papers)
- Partner nations
- United StatesIndiaJapan
In The Last Decade
Reema Railkar
18 papers receiving 334 citations
Peers
Comparison fields: 5 of 64
- Pulmonary and Respiratory Medicine 132
- Biotechnology 25
- Cancer Research 43
- Biomedical Engineering 121
- Oncology 60
Countries citing papers authored by Reema Railkar
This map shows the geographic impact of Reema Railkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reema Railkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reema Railkar more than expected).
Fields of papers citing papers by Reema Railkar
This network shows the impact of papers produced by Reema Railkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reema Railkar. The network helps show where Reema Railkar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Reema Railkar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 1 | |
| 2 | 2019 | 10 | |
| 3 | 2019 | 55 | |
| 4 | 2018 | 22 | |
| 5 | 2018 | 68 | |
| 6 | 2017 | 62 | |
| 7 | 2017 | 40 | |
| 8 | 2017 | 1 | |
| 9 | 2017 | 2 | |
| 10 | 2017 | 1 | |
| 11 | 2017 | 5 | |
| 12 | 2016 | 1 | |
| 13 | 2015 | 26 | |
| 14 | 2012 | 9 | |
| 15 | 2012 | 8 | |
| 16 | 2011 | 8 | |
| 17 | 2011 | 11 | |
| 18 | 2010 | 6 |
About Reema Railkar
Reema Railkar is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Pharmaceutical Science, having authored 18 papers that have together received 336 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (7 papers), Bladder and Urothelial Cancer Treatments (7 papers), Photodynamic Therapy Research Studies (6 papers), Cancer, Lipids, and Metabolism (3 papers), Cancer-related Molecular Pathways (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Nanoplatforms for cancer theranostics (3 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (132 citations), Biotechnology (25 citations) and Cancer Research (43 citations). Reema Railkar has collaborated with scholars based in United States, India and Japan. Frequent co-authors include Piyush K. Agarwal, Thomas Sanford, Hisataka Kobayashi, Peter L. Choyke, Diana C. Haines, Rajan R. Dighe, Ritankar Majumdar, Srinivas Vourganti, Sam J. Brancato and Daniel R. Crooks. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports, Cancer Research, Molecular Cancer Therapeutics and Clinical Epigenetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.